Dr.George Daley of Boston Children's Hospital explains the concept of Induced Pluripotent Stem Cells.

Read the original here:
IPs Cells Part 4

President Obama's lifting of federal restrictions on the use of embryonic stem cells in scientific research has generated considerable news coverage and many questions from our supporters about the impact of this reversal on our own research. Our most promising new stem cell investigations are on induced pluripotent stem cells (iPS), which are created by reverse-engineering cells from readily available skin samples. MRF COO Rusty Bromley has made this brief video about MRF's use of stem cells in myelin repair and the potential they offer for myelin repair in MS

More here:
Myelin Repair Foundation on Stem Cell Research

At Johns Hopkins, researchers and doctors are working together to explore the impact of stem technology on ALS. The Robert Packard Center for ALS Research at Johns Hopkins has helped uncover new genes for familial ALS, researched nerve repair, worked actively on genetic risk factors, developed a variety of animal models for testing therapies, explored ALS biology, advanced stem cell therapy, and researched ways to counter muscle atrophy.

See the original post:
Stem Cell Implications for ALS (Amyotrophic Lateral Sclerosis)

A brief overview of the milestones in stem cell research over that past 100 years.

Follow this link:
A Century of Stem Cells - Johns Hopkins Medicine

Dr. George Daley of Boston Children's Hospital explains the concept of Induced Pluripotent Stem Cells.

Read this article:
IPs cells Part 2

Dr.George Daley of Boston Children's Hospital explains the concept of Induced Pluripotent Stem Cells.

Follow this link:
IPs cells Part3

http://www.cellmedicine.com

Continued here:
Embryonic Stem Cells From Skin: Making Old Cells Young

Jeanne Loring talks about stem cells, part 2. Part of meeting between Parkinson's patients and researchers in Loring's lab about the potential of induced pluripotent stem cell therapy, Aug

Here is the original post:
Jeanne Loring talks about stem cells, part 2

Ying Liu, a Scripps Clinic researcher in the lab of stem cell scientist Jeanne Loring, discusses the biological underpinnings of the technology for using induced pluripotent stem cells for treated ALS, or Lou Gehrig's disease. For more information about the Loring lab, go to http://www.scripps.edu

Read this article:
Ying Liu discusses IPS cell therapy for ALS